Family Legacy Inc’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.62M | Sell |
10,418
-35
| -0.3% | -$7.53K | 0.7% | 56 |
|
|
2026
Q1 | $2.27M | Sell |
10,453
-30
| -0.3% | -$6.66K | 0.68% | 57 |
|
|
2025
Q4 | $2.4M | Sell |
10,483
-25
| -0.2% | -$5.7K | 0.72% | 55 |
|
|
2025
Q3 | $2.43M | Sell |
10,508
-50
| -0.5% | -$10.2K | 0.74% | 49 |
|
|
2025
Q2 | $1.96M | Buy |
10,558
+5
| +0% | +$929 | 0.64% | 61 |
|
|
2025
Q1 | $2.21M | Sell |
10,553
-87
| -0.8% | -$16.9K | 0.76% | 51 |
|
|
2024
Q4 | $1.9M | Buy |
10,640
+5
| +0% | +$919 | 0.64% | 59 |
|
|
2024
Q3 | $2.1M | Sell |
10,635
-40
| -0.4% | -$7.46K | 0.7% | 57 |
|
|
2024
Q2 | $1.83M | Sell |
10,675
-146
| -1% | -$24.2K | 0.66% | 59 |
|
|
2024
Q1 | $1.97M | Sell |
10,821
-305
| -3% | -$52.6K | 0.71% | 58 |
|
|
2023
Q4 | $1.72M | Buy |
11,126
+3
| +0% | +$437 | 0.66% | 58 |
|
|
2023
Q3 | $1.66M | Sell |
11,123
-67
| -0.6% | -$9.84K | 0.69% | 58 |
|
|
2023
Q2 | $1.51M | Sell |
11,190
-28
| -0.2% | -$4.11K | 0.61% | 60 |
|
|
2023
Q1 | $1.79M | Buy |
11,218
+275
| +3% | +$42K | 0.76% | 51 |
|
|
2022
Q4 | $1.62M | Sell |
10,943
-309
| -3% | -$47.4K | 0.71% | 58 |
|
|
2022
Q3 | $1.51M | Buy |
11,252
+134
| +1% | +$19.2K | 0.76% | 52 |
|
|
2022
Q2 | $1.7M | Sell |
11,118
-83
| -0.7% | -$12.7K | 0.8% | 51 |
|
|
2022
Q1 | $1.82M | Buy |
11,201
+142
| +1% | +$20.6K | 0.76% | 54 |
|
|
2021
Q4 | $1.51M | Buy |
11,059
+622
| +6% | +$73.5K | 0.62% | 61 |
|
|
2021
Q3 | $1.16M | Buy |
10,437
+86
| +0.8% | +$9.83K | 0.52% | 66 |
|
|
2021
Q2 | $1.22M | Buy |
10,351
+109
| +1% | +$12.3K | 0.54% | 64 |
|
|
2021
Q1 | $1.11M | Buy |
10,242
+229
| +2% | +$24.5K | 0.53% | 63 |
|
|
2020
Q4 | $1.07M | Buy |
10,013
+127
| +1% | +$12.2K | 0.55% | 63 |
|
|
2020
Q3 | $866K | Buy |
9,886
+823
| +9% | +$77.5K | 0.49% | 68 |
|
|
2020
Q2 | $890K | Buy |
9,063
+28
| +0.3% | +$2.46K | 0.54% | 62 |
|
|
2020
Q1 | $688K | Sell |
9,035
-80
| -0.9% | -$6.81K | 0.5% | 68 |
|
|
2019
Q4 | $816K | Sell |
9,115
-125
| -1% | -$10.4K | 0.46% | 69 |
|
|
2019
Q3 | $758K | Buy |
9,240
+3,543
| +62% | +$243K | 0.47% | 69 |
|
|
2019
Q2 | $414K | Buy |
5,697
+136
| +2% | +$10.7K | 0.32% | 80 |
|
|
2019
Q1 | $467K | Buy |
5,561
+256
| +5% | +$20.9K | 0.38% | 75 |
|
|
2018
Q4 | $489K | Buy |
5,305
+341
| +7% | +$30K | 0.44% | 71 |
|
|
2018
Q3 | $470K | Buy |
4,964
+113
| +2% | +$10.7K | 0.38% | 75 |
|
|
2018
Q2 | $449K | Buy |
4,851
+965
| +25% | +$94.2K | 0.39% | 73 |
|
|
2018
Q1 | $368K | Buy |
3,886
+171
| +5% | +$18.8K | 0.34% | 78 |
|
|
2017
Q4 | $359K | Buy |
+3,715
| New | +$350K | 0.32% | 79 |
|
|
2017
Q3 | – | Sell |
-3,810
| Closed | -$276K | – | 41 |
|
|
2017
Q2 | $276K | Hold |
3,810
| – | – | 0.28% | 81 |
|
|
2017
Q1 | $248K | Buy |
+3,810
| New | +$240K | 0.26% | 85 |
|
Other funds holding ABBV
Family Legacy Inc's ABBV Position: Q2 2026 in Review
Family Legacy Inc reduced its AbbVie (ABBV) stake by 0.33% in Q2 2026, selling an estimated $7.53K and leaving 10,418 shares worth $2.62M. The position accounts for 0.7% of the portfolio, ranked #56.
Family Legacy Inc first reported a position in ABBV in Q1 2017 and has held it in 37 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Family Legacy Inc held 10,418 shares of AbbVie worth $2.62M as of Q2 2026.
- Family Legacy Inc sold 35 AbbVie shares in Q2 2026, an estimated $7.53K.
- AbbVie made up 0.7% of Family Legacy Inc's portfolio in Q2 2026, its #56 holding.
- Family Legacy Inc first reported a position in AbbVie in Q1 2017 and has held it in 37 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Family Legacy Inc's 13F filing for Q2 2026, filed 6 Aug 2026.